Natixis
JNJ icon

Natixis’s Johnson & Johnson JNJ Stock Holding History

Natixis’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-185
Closed -$33K – 1123
2022
Q2 		$33K Buy
+185
New +$33K ﹤0.01% 1080

Other funds holding JNJ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Natixis's JNJ Position: Q3 2026 in Review

Natixis reduced its Johnson & Johnson (JNJ) stake by 57% in Q3 2026, selling an estimated $107M and leaving 303,731 shares worth $80.4M. The position accounts for 0.29% of the portfolio, ranked #42.

Natixis first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $355M in Q3 2017. 3,247 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Natixis held 303,731 shares of Johnson & Johnson worth $80.4M as of Q3 2026.
  • Natixis sold 404,059 Johnson & Johnson shares in Q3 2026, an estimated $107M.
  • Johnson & Johnson made up 0.29% of Natixis's portfolio in Q3 2026, its #42 holding.
  • Natixis first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Natixis's Johnson & Johnson position peaked at $355M in Q3 2017.
  • 3,247 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.